z-logo
open-access-imgOpen Access
Recurrent fetal hydrops with maternal M alloimmunisation: not a benign condition
Author(s) -
MingYang Yu,
Kathryn Graham,
Leonardo Pasalic,
Thushari I. Alahakoon
Publication year - 2019
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2019-230552
Subject(s) - medicine , fetus , hydrops fetalis , haemolysis , neonatal intensive care unit , obstetrics , pregnancy , intensive care unit , pediatrics , intensive care medicine , immunology , genetics , biology
Haemolytic disease of the fetus and newborn (HDFN) is associated with red cell antibodies. Anti-M usually results in a mild haemolysis and is rarely clinically significant. There is no established consensus on management of pregnancies with anti-M. A case of recurrent HDFN with maternal M alloimmunisation was identified at a tertiary hospital in Australia. We collected the patient and neonate's clinical and pathological data and interpreted the case with available literature. This is the first case in literature of recurrent fetal hydrops in the setting of M alloimmunisation. Neonate was delivered in a poor condition, intubated and admitted to the neonatal intensive care unit for ionotropic support, red cell transfusion and plasma transfusion for coagulopathy. Direct Coombs test was positive, confirming HDFN. Although anti-M rarely causes HDFN, accurate history, fetal surveillance and monitoring is essential for identification of fetal anaemia. Concurrent placental disease may increase fetal risk from anti-M antibodies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here